Flora Smith
Family Medicine · Saint Clair Shores, MINPI 1710455845
Payments from drug & device makers
Across 315 payments — averaging $24.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Sanofi$810
- Takeda Pharmaceuticals U.S.A., Inc.$611
- GSK$488
- Regeneron Healthcare Solutions, Inc.$415
- AbbVie$399
- plus $3K from 26 others
What the payments were for
- Food & beverage$7,37997%
- Education$1993%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 84 | $2,139 |
| Sanofi | 31 | $810 |
| Takeda Pharmaceuticals U.S.A., Inc. | 22 | $611 |
| GSK | 26 | $488 |
| Regeneron Healthcare Solutions, Inc. | 15 | $415 |
| AbbVie | 8 | $399 |
| Amgen | 25 | $385 |
| CSL Behring | 16 | $362 |
| Pfizer | 13 | $258 |
| Boehringer Ingelheim | 11 | $247 |
| Novartis | 10 | $203 |
| Pharming Healthcare, Inc. | 8 | $187 |
| Biocryst US Sales Co., LLC | 5 | $139 |
| Blueprint Medicines Corporation | 5 | $128 |
| Kaleo, Inc. | 5 | $121 |
| Otsuka America Pharmaceutical, Inc. | 6 | $108 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Alk-abello, Inc | 4 | $81 |
| Optinose US, Inc. | 3 | $79 |
| Lundbeck LLC | 3 | $56 |
| Alkermes, Inc. | 2 | $39 |
| Phadia US Inc. | 2 | $38 |
| Ionis Pharmaceuticals, Inc. | 1 | $32 |
| Viatris Specialty LLC | 1 | $25 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $23 |
| Paratek Pharmaceuticals, Inc. | 1 | $21 |
| Hospira, Inc. | 1 | $19 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
| OWP Pharmaceuticals, Inc. | 1 | $16 |
| Hikma Pharmaceuticals USA | 1 | $14 |
| Dermavant Sciences, Inc. | 1 | $14 |
| Organon | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,579 in reported general payments places this provider in the 95th percentile of 3,945 family medicine providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 13 | $48,914 |
| Breo ElliptaFluticasone/Vilanterol | 67 | $28,366 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 26 | $26,154 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 32 | $22,038 |
| Spiriva RespimatTiotropium Bromide | 24 | $12,289 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 18 | $4,133 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 21 | $3,929 |
| Epinephrine | 15 | $3,623 |
| Azelastine Hcl | 85 | $3,163 |
| Wixela InhubFluticasone Propion/Salmeterol | 14 | $2,818 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 86 | $2,756 |
| Fluticasone Propionate | 107 | $2,214 |
| Montelukast Sodium | 127 | $1,951 |
| Ventolin HfaAlbuterol Sulfate | 14 | $892 |
| Aripiprazole | 13 | $603 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKBreo Ellipta, Trelegy Ellipta | $488 | $54,52093 claims |
| AstraZenecaBreztri Aerosphere | $2,139 | $22,03832 claims |
| Boehringer IngelheimSpiriva Respimat | $247 | $12,28924 claims |
| Hikma Pharmaceuticals USAEpinephrine | $14 | $3,62315 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,945 family medicine providers in Michigan.
Other family medicine in Saint Clair Shores
- Derrick WilliamsonSouthfield$9.9M
- Rebecca RivardRoseville$7M
- Paul BensonBerkley$4.2M
- Michael HafranEast Lansing$2.7M
- Mitzie HewittBuckley$1.3M
- Loren ChudlerSouthfield$1.3M
- Solomon AmsterWhite Lake$981K
- Matt RosenbergJackson$559K
- Rhonda MejeurGrand Rapids$493K
- Steve LasaterSaint Johns$291K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.